Simplify Logo

Full-Time

Senior Scientist I

Analytical Development CMC

Posted on 8/26/2024

Cytokinetics

Cytokinetics

201-500 employees

Develops drugs for muscle function improvement

Biotechnology
Healthcare

Compensation Overview

$150k - $183kAnnually

Senior, Expert

San Bruno, CA, USA

Category
Bioinformatics
Biology Lab & Research
Biology & Biotech
Requirements
  • Master’s or Ph.D. in Chemistry, organic chemistry, Biochemistry, or a related field with 6+ years of relevant industrial experience in analytical development, with a strong emphasis on small molecules
  • Expertise in HPLC, GC, FTIR, Vis/UV, mass spectroscopy, XRPD, PSD, KF, and other relevant analytical methodologies
  • Proven ability to manage and collaborate with external partners like CROs and CMOs
  • Effective written and verbal communication skills and interpersonal skills
  • Extensive knowledge and understanding of current ICH guidelines, USP procedures, GMP guidelines, and related industry practices
  • Strong problem-solving skills with sound technically driven decision-making ability
  • Excellent scientific and business communication skills (verbal, written and technical), strong interpersonal/collaboration skills and planning skills
  • Ability to think critically and creatively and be able to work independently to determine appropriate resources for resolution of problems
  • Ability to multi-task and thrive in a fast-paced innovative environment
  • Experiences with Veeva or TrackWise is a plus
Responsibilities
  • Oversee and manage analytical activities in CROs and CMOs as a subject matter expert for Analytical Development function
  • Work with contract manufacturers to develop, validate, and transfer methods or trouble shoot as needed
  • Coordinate and oversee analytical testing for release and stability studies for drug substances and drug products to ensure compliance with quality standards
  • Review analytical methods, validation protocols, reports, and analytical data (in-process, release, and stability data) packets
  • Participate in the establishment and justification of all specifications for drug substances and drug products
  • Provide analytical expertise for manufacturing and testing deviations, OOS/OOT investigations working in concert with Quality Assurance to ensure proper disposition of affected materials
  • Manage the reference standard qualification and recertification
  • Work closely with internal Quality Assurance (QA), Process Chemistry, and Drug Product groups to ensure seamless integration and alignment of analytical methods and product quality
  • Maintain comprehensive documentation of all analytical test results and method validation activities to support regulatory and internal requirements
  • Review/author internal or externally generated technical documents and analytical sections of INDs as needed
  • Represents Analytical Development at interdepartmental meetings

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

South San Francisco, California

Founded

1998

Growth & Insights
Headcount

6 month growth

0%

1 year growth

1%

2 year growth

21%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful Phase III trial results for aficamten in treating obstructive hypertrophic cardiomyopathy (HCM) highlight the company's potential for market leadership in this area.
  • The $575M funding from Royalty Pharma ensures strong financial support for the commercial launch of aficamten and further R&D activities.
  • Recent investments and stock offerings indicate strong investor confidence and provide additional capital for growth and development.

What critics are saying

  • The late-stage biopharmaceutical market is highly competitive, with significant pressure to bring drugs to market quickly and efficiently.
  • Dependence on the success of clinical trials and regulatory approvals poses inherent risks, as any setbacks could delay commercialization and revenue generation.

What makes Cytokinetics unique

  • Cytokinetics focuses on muscle function improvement for cardiovascular and neuromuscular diseases, a niche area with high unmet medical needs.
  • The company has a robust pipeline of small molecule muscle activators and inhibitors, setting it apart from competitors with more generalized drug portfolios.
  • Strategic funding collaborations, such as the $575M deal with Royalty Pharma, provide significant financial backing for their R&D and commercialization efforts.
INACTIVE